Simplex Trading’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-25
Closed -$3K 8276
2018
Q3
$3K Buy
+25
New +$28 ﹤0.01% 7023
2017
Q2
Sell
-525
Closed -$2K 7176
2017
Q1
$2K Buy
525
+221
+73% +$1K ﹤0.01% 5438
2016
Q4
$14K Buy
+304
New +$1.6K ﹤0.01% 3433
2016
Q3
Sell
-53
Closed -$2K 6802
2016
Q2
$2K Buy
+53
New +$278 ﹤0.01% 5091
2016
Q1
Sell
-65
Closed -$1K 6615
2015
Q4
$1K Sell
65
-39
-38% -$265 ﹤0.01% 5131
2015
Q3
$8K Buy
+104
New +$806 ﹤0.01% 3680
2015
Q2
Sell
-18
Closed -$3K 6159
2015
Q1
$3K Buy
+18
New +$136 ﹤0.01% 3962

Simplex Trading's GNMX Position: Q1 2020 in Review

Simplex Trading sold out of Aevi Genomic Medicine Inc (GNMX) in Q1 2020, closing a stake of 100 shares.

Simplex Trading first reported a position in GNMX in Q4 2014 and held it in 12 quarters. The position peaked at $15K in Q4 2015. 2 funds tracked by Wall St. Rank hold GNMX as of Q1 2020.

  • Simplex Trading reported no remaining Aevi Genomic Medicine Inc position as of Q1 2020 after selling out during the quarter.
  • Simplex Trading sold 100 Aevi Genomic Medicine Inc shares in Q1 2020.
  • Simplex Trading first reported a position in Aevi Genomic Medicine Inc in Q4 2014 and held it in 12 quarters.
  • Simplex Trading's Aevi Genomic Medicine Inc position peaked at $15K in Q4 2015.
  • 2 funds tracked by Wall St. Rank held Aevi Genomic Medicine Inc as of Q1 2020.

Based on Simplex Trading's 13F filing for Q1 2020, filed 29 Apr 2020.